BIOMARIN PHARMACEUTICAL INC Available-for-sale Securities
BIOMARIN PHARMACEUTICAL INC (BMRN) had Available-for-sale Securities of $1.64 billion as of 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-08-03
- 2018-06-30: Available-for-sale Securities $1.64B.
- 2018-03-31: Available-for-sale Securities $1.70B.
- 2017-12-31: Available-for-sale Securities $1.78B; Available-for-sale Securities as first filed $1.23B.
- 2017-09-30: Available-for-sale Securities $1.24B.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2018-06-30 | $1.64B 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $1.70B 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $1.78B 10-Q · filed 2018-08-03 | $1.23B 10-K · filed 2018-02-26 |
| 2017-09-30 | $1.24B 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $856.66M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $863.45M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $968.65M 10-K · filed 2018-02-26 | $954.06M 10-K · filed 2017-02-27 |
| 2016-09-30 | $690.46M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $398.94M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $500.80M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $621.23M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $756.37M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $750.52M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $332.04M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $167.56M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $716.70M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $496.05M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $499.15M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $483.64M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $345.86M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $349.02M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $371.32K 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $383.27M 10-K · filed 2014-02-26 | $386.20K 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |